Clinical trials
Phase 3 Adenocarcinoma trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott | 1 |
| Ariad Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Chinese University of Hong Kong | 1 |
| Daiichi Sankyo | 1 |
| Genzyme, a Sanofi Company | 1 |
| Imunon | 1 |
| Queensland Centre for Gynaecological Cancer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 11 |
| Carcinoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 4 |
| Digestive System Diseases | 3 |
| Digestive System Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Large Cell | 2 |
| Carcinoma, Squamous Cell | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.